DODGEVILLE, Wis., July 13, 2026 (GLOBE NEWSWIRE) — Lands’ End, Inc. (Nasdaq: LE) today reported that it made the following inducement grants to Charlie Cole on July 13, 2026, in connection with his commencement of employment and appointment as Chief Executive Officer. The grants were not made under a shareholder approved equity plan and were previously described in a Current Report on Form 8-K filed by Lands’ End with the Securities and Exchange Commission on June 30, 2026. Mr. Cole’s inducement grants consist of an inducement sign-on grant of 109,361 restricted stock units, payable in the form of shares of Lands’ End, Inc. common stock (“Common Stock”), and an inducement sign-on grant of options to purchase up to 166,018 shares of Common Stock at an exercise price equal to $11.43 per share, which in each case will vest 25%, 25%...

TORONTO, July 13, 2026 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced select preliminary unaudited financial results for the three-month period ended June 30, 2026, based on preliminary financial information currently available to management, which are expected to meaningfully exceed management’s prior expectations for the quarter. The Company continues to finalize its financial results and therefore has not yet completed its customary quarter-end review procedures. “We are pleased with the strength of our second quarter performance,” said Mike Reeves, President and Chief Executive Officer. “Order capture across our wire and cable markets was stronger than previously anticipated, while continued operational efficiency improvements across our modernized manufacturing network, particularly...

HOUSTON, July 13, 2026 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced that it will hold Special Shareholder Meetings on September 3, 2026, to consider the Company’s proposed redomestication from Ireland to Delaware. The definitive proxy statement for the meetings was filed with the U.S. Securities and Exchange Commission today and is being distributed to all shareholders. The Weatherford Board of Directors unanimously recommends that shareholders vote FOR all proposals related to the proposed redomestication, which the Board believes will simplify the Company’s organizational, statutory and regulatory structure while creating a more appropriate corporate framework to support Weatherford’s long-term strategy. The expected financial benefits for Weatherford...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the “Private Placement”). The Company issued an aggregate of 5,000,000 units of the Company (the “Units”) at a price of $0.30 per Unit for gross proceeds of $1,500,000. Each Unit is comprised of one common share (each a “Share”) and one Share purchase warrant (each a “Warrant”). Each Warrant entitles the holder to purchase one Share at an exercise price of $0.45 for a period of 24 months from the closing date of the Private Placement. The Warrants are subject to a 60-day hold period. The net proceeds...

LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose planned for late August 2026 TOKYO and CAMBRIDGE, Mass., July 13, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) as an initiation dose for the treatment of early Alzheimer’s disease. LEQEMBI IQLIK is administered via an autoinjector, introducing a convenient alternative to intravenous (IV) dosing from the start of treatment. For initiation, the approved regimen is 500 mg given once weekly as two 250 mg...

Conference Call to Discuss Results Scheduled for July 29, 2026 PARSIPPANY, N.J., July 13, 2026 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its second quarter 2026 financial results after the market close on Tuesday, July 28, 2026, and to host a conference call for institutional investors to discuss these results on Wednesday, July 29, 2026, at 8:30 a.m. Eastern time. Investors may access the call via the Company’s Investor Relations website at ir.avisbudgetgroup.com, or by dialing 877-407-2991. Investors are encouraged to dial in approximately 10 minutes prior to the start of the call. A webcast replay will be available at ir.avisbudgetgroup.com following the call. A telephone replay will be available from 12:30 p.m. Eastern time on July 29, 2026, until 10:00 p.m. Eastern time...

LAS VEGAS, July 13, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (NASDAQ: JTAI) (“Jet.AI” or the “Company”), an emerging provider of high-performance GPU infrastructure and AI cloud services, announced the successful closing of its merger transaction with flyExclusive, Inc. (“flyExclusive”), following stockholder approval at the Company’s reconvened Special Meeting of Stockholders and satisfaction of all remaining customary closing conditions. In connection with the distribution, Jet.AI stockholders of record as of the close of business on July 6th, 2026, the record date for the distribution of shares of Jet.AI SpinCo, Inc. (“SpinCo”) common stock, were entitled to receive, on a pro rata basis, all outstanding shares of SpinCo, at a ratio of one share of SpinCo common stock for each share of the Company’s common stock. The distribution...

Board Urges Shareholders to Follow Recommendations and Vote FOR Proposed Transaction with Thoma Bravo to Realize Significant, Immediate, and Certain Value LIMERICK, Ireland, July 13, 2026 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), (“Kneat” or the “Company”), the global leader in digital validation and quality process automation today announced that leading proxy advisory firms Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis have both recommended that Kneat shareholders vote “FOR” the arrangement agreement (the “Proposed Transaction”) whereby Kneat will be acquired by an affiliate of Thoma Bravo, L.P. (“Thoma Bravo”) at the upcoming Special Meeting of Shareholders (the “Meeting”), to be held on July 30, 2026 at 10:00 a.m. Toronto time. Kneat shareholders of record as of June 25, 2026, are eligible...